Static Chart Scholar Rock Holding Corporation

Stocks

Market Closed - Nasdaq 21:00:00 09/09/2026 BST			5-day change	1st Jan Change
54.62 ^USD	-4.88%		-2.64%	+24.00%

09-02	Scholar Rock Receives FDA Fast Track Designation For Apitegromab Facioscapulohumeral Muscular Dystrophy Program As Participant Dosing Commences In Phase 2 FORGE Trial	CI
09-02	Scholar Rock Gets FDA Fast Track, Orphan Drug Designations for Muscular Disorder Drug	MT

Duration

Period